Results 201 to 210 of about 2,607,441 (255)
Some of the next articles are maybe not open access.
Mechanical and Enzymatic Thrombolysis for Massive Pulmonary Embolism
Journal of Vascular and Interventional Radiology, 2002To assess the efficacy and safety of mechanical fragmentation combined with intrapulmonary thrombolysis in massive pulmonary thromboembolism (PTE) with hemodynamic impairment.Fifty-nine patients diagnosed with massive PTE with hemodynamic impact were treated. The initial clinical symptoms were shock in 23 patients (38.9%), syncope in eight (13.5%), and
Miguel A De Gregorio, Mario Fava
exaly +3 more sources
Mechanical intervention after thrombolysis
Journal of Cardiovascular Medicine, 2008Revascularisation strategies for acute myocardial infarction have evolved from early admission to coronary care units, bed rest and cardiac rhythm monitoring, to thrombolytic therapy and primary angioplasty. Although mechanical intervention for a failed prior revascularisation attempt is common widespread clinical practice, the outcome of this two-step
Peels, Hans O. J. +3 more
openaire +3 more sources
Some Aspects of the Mechanism of Thrombolysis
Thrombosis and Haemostasis, 1961Summary1. Antibody to streptokinase and kinase, activator and plasmin inhibitors in the circulating blood of man, inhibit parenterally injected streptokinase and streptokinase-plasmin, in vivo. In vitro assays of these inhibitors determine the priming dose of streptokinase and streptokinase-plasmin to neutralize the inhibitors and effect thrombolysis.2.
A J, JOHNSON, W R, McCARTY
openaire +2 more sources
2001
The pharmacological use of plasminogen activators is associated with symptomatic improvement in patients with coronary artery thrombosis, peripheral arterial occlusions, and thrombosis of the venous system. Based on prospective angiographic studies and planned programs (1, 2, 3, 4, 5), thrombolysis is the only approved treatment of acute ischemic ...
Gregory J. Zoppo, Naohisa Hosomi
openaire +1 more source
The pharmacological use of plasminogen activators is associated with symptomatic improvement in patients with coronary artery thrombosis, peripheral arterial occlusions, and thrombosis of the venous system. Based on prospective angiographic studies and planned programs (1, 2, 3, 4, 5), thrombolysis is the only approved treatment of acute ischemic ...
Gregory J. Zoppo, Naohisa Hosomi
openaire +1 more source
Mechanisms of ultrasonic thrombolysis
2009 38th Annual Symposium of the Ultrasonic Industry Association (UIA), 2009An ultrasonic transversely vibrating wire delivers energy to an active zone to facilitate thrombolysis in a blood vessel. Ultimately, all the energy delivered into the treatment region at the active zone ends up as heat. The heat created can originate from three sources.
Jeffrey J. Vaitekunas +2 more
openaire +1 more source
Percutaneous Mechanical Thrombolysis
Investigative Radiology, 1991Schmitz-Rode T, Gunther RW. Percutaneous mechanical thrombolysis: a comparative study of various rotational catheter systems. Invest Radiol 1991;26:557-563. In vitro fragmentation of thrombi was performed with the Kensey catheter, the Bildsoe catheter, the Gunther aspiration catheter, and two modified aspiration catheters in a model circuit under ...
THOMAS SCHMITZ-RODE, ROLF W. G??NTHER
openaire +1 more source
Successful thrombolysis on a mechanical tricuspid prosthesis
European Heart Journal, 1989Recombinant tissue-type plasminogen activator (rt-PA) is presently used for the treatment of different clinical entities, mostly myocardial infarction. Its use for treatment of thrombotic dysfunction of prosthetic cardiac valves is more recent and has been only rarely reported.
M A, Prieto Palomino +6 more
openaire +2 more sources
Mechanical Fragmentation and Pharmacologic Thrombolysis in Massive Pulmonary Embolism
PURPOSE: To evaluate the usefulness of mechanical fragmentation associated with intrapulmonary thrombolysis in acute massive pulmonary embolism (PE).PATIENTS AND METHODS: Sixteen cases of massive PE treated with mechanical fragmentation associated with ...
Mario Fava, Soledad Loyola
exaly +2 more sources
Molecular mechanisms of thrombolysis: Implications for therapy
Biochemical Pharmacology, 1990The review deals with the molecular mechanism of action and with the thrombolytic properties of streptokinase, recombinant tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex (APSAC)
D, Collen, H R, Lijnen
openaire +2 more sources
Thrombolysis and mechanical thrombectomy for arterial disease
Surgical Clinics of North America, 2004Thrombolytic therapy has been around for close to 30 years now,but its exact role in the treatment of acute and chronic arterial occlusive disease continues to be debated. Studies have produced varying and contradictory results. We are still not sure if thrombolysis has any true advantages over surgical thromboembolectomy,or which lytic agent is the ...
Zachary C, Schmittling, Kim J, Hodgson
openaire +2 more sources

